-
GIVING A VOICE TO PATIENTS IN DRUG REIMBURSEMENT: A CROSS-COUNTRY COMPARATIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND CONTENT VALIDATION OF A WELL-BEING INSTRUMENT FOR YOUNGER POPULATIONS IN ECONOMIC EVALUATIONS: THE WELL-BEING OF YOUTH INSTRUMENT (WELL-Y)
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE STUDY OF TREATMENT PATTERNS IN PEDIATRIC AND ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN ALBERTA
Aug 11, 2026, 17:16 PM -
BEYOND CLAIMS DATA: A LEGALLY GOVERNED INTEGRATED EHR-CLAIMS DATABASE FOR REAL-WORLD EVIDENCE GENERATION IN JAPAN
Aug 11, 2026, 17:16 PM -
EXPERIMENTED LONG-ACTING INJECTABLE ANTIRETROVIRAL THERAPY AND LINK WITH AMBULATORY MEDICINE AMONG ADULT PEOPLE LIVING WITH HIV: THE REAL-LIFE PANTER STUDY
Aug 11, 2026, 17:16 PM -
UNIVERSAL NIRSEVIMAB VERSUS MATERNAL RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNIZATION: A COST-EFFECTIVENESS ANALYSIS IN BRAZIL
Aug 11, 2026, 17:16 PM -
CLINICAL ROLES OF AI-INTEGRATED ELECTROCEUTICALS FOR NEUROTRANSMITTER DYSREGULATION DISORDERS: A NARRATIVE REVIEW
Aug 11, 2026, 17:16 PM -
COMPARATIVE ANALYSIS OF MEDICAL COSTS AND HEALTHCARE RESOURCE UTILIZATION (HCRU) BETWEEN INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB IN BRAZILIAN PRIVATE ONCOLOGY PATIENTS: A RETROSPECTIVE REAL-WORLD...
Aug 11, 2026, 17:16 PM -
WILLINGNESS TO PAY FOR HEALTH INSURANCE: A SYSTEMATIC REVIEW OF CONTINGENT VALUATION STUDIES IN UPPER-MIDDLE- AND HIGH-INCOME COUNTRIES IN AFRICA AND EURASIA
Aug 11, 2026, 17:16 PM -
A SYSTEMATIC LITERATURE REVIEW (SLR) AND INDIRECT TREATMENT COMPARISON (ITC) FEASIBILITY ASSESSMENT OF THE COMPARATIVE EFFICACY OF TREATMENTS IN HER2+, RAS WILD-TYPE (WT), METASTATIC COLORECTAL CANCER (MCRC)
Aug 11, 2026, 17:16 PM -
FROM TRIAL ENDPOINT TO REAL-WORLD REGISTRY: THE FATE OF PROS IN AIFA MONITORING
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PCV20 COMPARED WITH PCV15 FOLLOWED BY PPSV23 AMONG ADULTS IN SOUTH KOREA
Aug 11, 2026, 17:16 PM -
EVALUATING AI-ASSISTED LITERATURE REVIEW PLATFORMS AT TASK-LEVEL AGAINST HUMAN-LED BASELINES
Aug 11, 2026, 17:16 PM -
DEFINING REQUIREMENTS FOR EVIDENCE TRANSFER FROM ADULT TO PEDIATRIC POPULATIONS: INSIGHTS FROM THE GERMAN EARLY BENEFIT ASSESSMENT
Aug 11, 2026, 17:16 PM -
PATIENT REPORTED OUTCOMES ASSOCIATED WITH NON-TREATMENT: A REAL-WORLD OUTCOMES EVALUATION OF ATRIAL FIBRILLATION PATIENTS NOT RECEIVING ORAL ANTICOAGULATION
Aug 11, 2026, 17:16 PM -
BEYOND CONTAMINATED COMPARATORS: VALIDATING A G-COMPUTATION FRAMEWORK FOR TREATMENT SWITCHING IN ONCOLOGY NMAS
Aug 11, 2026, 17:16 PM -
PRICE DIFFERENTIALS AND TIME-TO-FINANCING FOR NEW ONCOLOGY MEDICINES IN SPAIN VERSUS THE UNITED STATES: IMPLICATIONS OF US MOST-FAVORED-NATION PRICING AND SPAIN'S PRICING REFORM
Aug 11, 2026, 17:16 PM -
REVIEW AND CURATE ONCE, REUSE MULTIPLE TIMES: AN ONCOLOGY RWE LIVING EVIDENCE LIBRARY FRAMEWORK
Aug 11, 2026, 17:16 PM -
REAL-WORLD TREATMENT PATTERNS AND CAR-T THERAPY UTILIZATION AMONG MEDICARE BENEFICIARIES WITH DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
BRIDGING ANIMAL AND OWNER PERSPECTIVES: LINGUISTIC VALIDATION OF COMPANION ANIMAL QUALITY OF LIFE MEASURES
Aug 11, 2026, 17:16 PM
